Homi Adajania put his film, Angrezi Medium, on hold only for Irrfan Khan. The actor was diagnosed with a neuroendocrine tumour in 2018 and underwent treatment for the same for a year and a half. During the shoot of the film, there were good days and bad days as the actor was undergoing treatment, however, he successfully completed the shoot of the film. Tomorrow, the film will release and Irrfan Khan's wait will be worth it. Angrezi Medium has received rave reviews from the critics already and it is up to the audience to decide the fate of the film.
Meanwhile, when Homi Adajania was asked about Irrfan's comeback, he put forth a strong statement and said, "A legend doesn’t come back. He’s always there." The director further mentioned that he had decided to make this film with Irrfan or not make it at all.
"While the making of the movie, Irrfan was undergoing treatment, so there would be good days and bad days. There was an uncertainty about his energy levels, considering how difficult shoots can be. I did put everything on hold and decided to wait for him to make this. Dinoo (Dinesh Vijan, producer) and I were very clear that Angrezi Medium would be made with Irrfan only. And I took the risk, knowing that it would be an experience that my crew and I would cherish," he told Hindustan Times.
Homi also spoke about his working experience with the rest of the star cast that includes Radhika Madan, Deepak Dobriyal, Dimple Kapadia and Kareena Kapoor Khan. He said, "Kareena is a very intuitive actor. Acting courses through her veins and she is very easy to direct. I feel Radhika has a very bright future as an actor because she is fearless and hungry to learn. Dimple is uninhibited as an actor and more so as a human being. We both are a little crazy and love having a laugh."
Stay tuned to this space for more scoops and updates.
Vote for social media king here:
Stay tuned to BollywoodLife for the latest scoops and updates from Bollywood, Hollywood, South, TV and Web-Series.
Click to join us on Facebook, Twitter, Youtube and Instagram. Also follow us on Facebook Messenger for latest updates.